View Future GrowthTelescope Innovations 過去の業績過去 基準チェック /06Telescope Innovationsは20.9%の年平均成長率で業績を伸ばしているが、Life Sciences業界はdecliningで3.5%毎年増加している。売上は成長しており、年平均49.6%の割合である。主要情報20.86%収益成長率35.28%EPS成長率Life Sciences 業界の成長21.51%収益成長率49.65%株主資本利益率-120.64%ネット・マージン-56.03%前回の決算情報31 May 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • 1hTelescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirementsお知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.収支内訳Telescope Innovations の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:TELI.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費31 May 267-410028 Feb 267-38030 Nov 256-28031 Aug 255-26031 May 254-25028 Feb 254-25030 Nov 244-24031 Aug 244-14031 May 244-14029 Feb 244-14030 Nov 23403031 Aug 233-13031 May 233-14028 Feb 232-24030 Nov 221-55031 Aug 221-65031 May 220-64028 Feb 220-83030 Nov 210-51031 Aug 210-41031 May 210-30028 Feb 21000030 Nov 200000質の高い収益: TELI.Fは現在利益が出ていません。利益率の向上: TELI.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: TELI.Fは利益を出していないが、過去 5 年間で年間20.9%の割合で損失を削減してきた。成長の加速: TELI.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: TELI.Fは利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( 5.2% ) と比較することは困難です。株主資本利益率高いROE: TELI.Fは現在利益が出ていないため、自己資本利益率 ( -120.64% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/15 01:29終値2026/07/15 00:00収益2026/05/31年間収益2025/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Telescope Innovations Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • 1hTelescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").
お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.
お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.
お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirements
お知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.
お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.
お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.
お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.
お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.
お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.